Gait analysis has been widely studied by researchers due to the impact in clinical fields. It provides relevant information on the condition of a patient’s pathologies. In the last decades, different gait measurement methods have been developed in order to identify parameters that can contribute to gait cycles. Analyzing those parameters, it is possible to segment and identify different phases of gait cycles, making these studies easier and more accurate. This paper proposes a simple gait segmentation method based on plantar pressure measurement. Current methods used by researchers and clinicians are based on multiple sensing devices (e.g., multiple cameras, multiple inertial measurement units (IMUs)). Our proposal uses plantar pressure information from only two sensorized insoles that were designed and implemented with eight custom-made flexible capacitive sensors. An algorithm was implemented to calculate gait parameters and segment gait cycle phases and subphases. Functional tests were performed in six healthy volunteers in a 10 m walking test. The designed in-shoe insole presented an average power consumption of 44 mA under operation. The system segmented the gait phases and sub-phases in all subjects. The calculated percentile distribution between stance phase time and swing phase time was almost 60%/40%, which is aligned with literature reports on healthy subjects. Our results show that the system achieves a successful segmentation of gait phases and subphases, is capable of reporting COP velocity, double support time, cadence, stance phase time percentage, swing phase time percentage, and double support time percentage. The proposed system allows for the simplification of the assessment method in the recovery process for both patients and clinicians.

After Stroke Movement Impairments: A Review of Current Technologies for Rehabilitation | InTechOpen, Published on: 2017-06-14. Authors: Pablo Aqueveque, Paulina Ortega, Esteban Pino, et

Background: Diaphragm muscle atrophy during mechanical ventilation begins within 24 h and progresses rapidly with significant clinical consequences. Electrical stimulation of the phrenic nerves using invasive electrodes has shown promise in maintaining diaphragm condition by inducing intermittent diaphragm muscle contraction. However, the widespread application of these methods may be limited by their risks as well as the technical and environmental requirements of placement and care. Non‐invasive stimulation would offer a valuable alternative method to maintain diaphragm health while overcoming these limitations.Methods: We applied non‐invasive electrical stimulation to the phrenic nerve in the neck in healthy volunteers. Respiratory pressure and flow, diaphragm electromyography and mechanomyography, and ultrasound visualization were used to assess the diaphragmatic response to stimulation. The electrode positions and stimulation parameters were systematically varied in order to investigate the influence of these parameters on the ability to induce diaphragm contraction with non‐invasive stimulation.Results: We demonstrate that non‐invasive capture of the phrenic nerve is feasible using surface electrodes without the application of pressure, and characterize the stimulation parameters required to achieve therapeutic diaphragm contractions in healthy volunteers. We show that an optimal electrode position for phrenic nerve capture can be identified and that this position does not vary as head orientation is changed. The stimulation parameters required to produce a diaphragm response at this site are characterized and we show that burst stimulation above the activation threshold reliably produces diaphragm contractions sufficient to drive an inspired volume of over 600 ml, indicating the ability to produce significant diaphragmatic work using non‐invasive stimulation.Conclusion: This opens the possibility of non‐invasive systems, requiring minimal specialist skills to set up, for maintaining diaphragm function in the intensive care setting.

The locus coeruleus–norepinephrine system is thought to be involved in the clinical effects of vagus nerve stimulation. This system is known to prevent seizure development and induce long-term plastic changes, particularly with the release of norepinephrine in the hippocampus. However, the requisites to become responder to the therapy and the mechanisms of action are still under investigation. Using MRI, we assessed the structural and functional characteristics of the locus coeruleus and microstructural properties of locus coeruleus-hippocampus white matter tracts in patients with drug-resistant epilepsy responding or not to the therapy. Twenty-three drug-resistant epileptic patients with cervical vagus nerve stimulation were recruited for this pilot study, including 13 responders or partial responders and 10 non-responders. A dedicated structural MRI acquisition allowed in vivo localization of the locus coeruleus and computation of its contrast (an accepted marker of LC integrity). Locus coeruleus activity was estimated using functional MRI during an auditory oddball task. Finally, multi-shell diffusion MRI was used to estimate the structural properties of locus coeruleus-hippocampus tracts. These characteristics were compared between responders/partial responders and non-responders and their association with therapy duration was also explored. In patients with a better response to the therapy, trends toward a lower activity and a higher contrast were found in the left medial and right caudal portions of the locus coeruleus, respectively. An increased locus coeruleus contrast, bilaterally over its medial portions, correlated with duration of the treatment. Finally, a higher integrity of locus coeruleus-hippocampus connections was found in patients with a better response to the treatment. These new insights into the neurobiology of vagus nerve stimulation may provide novel markers of the response to the treatment and may reflect neuroplasticity effects occurring in the brain following the implantation.

This extended paper presents the development and implementation at a prototype level of a wireless, low-cost system for the measurement of the electrical bioimpedance of the chest with two channels using the AD5933 in a bipolar electrode configuration to measure impedance pneumography. The measurement device works for impedance measurements ranging from 1 Ω to 1800 Ω. Fifteen volunteers were measured with the prototype. We found that the left hemithorax has higher impedance compared to the right hemithorax, and the acquired signal presents the phases of the respiratory cycle with variations between 1 Ω, in normal breathing, to 6 Ω in maximum inhalation events. The system can measure the respiratory cycle variations simultaneously in both hemithorax with a mean error of −0.18 ± 1.42 BPM (breaths per minute) in the right hemithorax and −0.52 ± 1.31 BPM for the left hemithorax, constituting a useful device for the breathing rate calculation and possible screening applications.

This study investigates the dose-dependent EEG effects of Vagus Nerve Stimulation (VNS) in patients with drug-resistant epilepsy. This research examines how varying VNS intensities impacts EEG power spectrum and synchronization in a cohort of 28 patients. Patients were categorized into responders, partial-responders, and non-responders based on seizure frequency reduction. The methods involved EEG recordings at incremental VNS intensities, followed by spectral and synchronization analysis. The results reveal significant changes in EEG power, particularly in the delta and beta bands across different intensities. Notably, responders exhibited distinct EEG changes compared to non-responders. Our study has found that VNS intensity significantly influences EEG power topographic allocation and brain desynchronization, suggesting the potential use of acute dose-dependent effects to personalized VNS therapy in the treatment of epilepsy. The findings underscore the importance of individualized VNS dosing for optimizing therapeutic outcomes and highlight the use of EEG metrics as an effective tool for monitoring and adjusting VNS parameters. These insights offer a new avenue for developing individualized VNS therapy strategies, enhancing treatment efficacy in epilepsy.